Newest Cancer Therapies Multi-Task to Eliminate Tumors

Some of the newest therapies in the war on cancer remove the brakes cancer puts on the immune system, Georgia Health Sciences University researchers report.

These immunotherapies, such as CTLA4, strengthen the immune system’s attack on cancer by keeping apart two proteins that prevent key immune cells called T cells from activating.

Research featured on the cover of the Journal of Immunology suggests that these therapies also keep tumors from benefiting from IDO, an enzyme used by fetuses and tumors alike to suppress the immune response.

“This is an alternative way of avoiding the immune system brakes,” said Dr. Andrew Mellor, Director of the GHSU Immunotherapy Center and the study’s corresponding author. “These findings give us better insight into how cancer immunotherapy works so in the future we can better minimize the side effects and maximize the effect we want which is anti-tumor.”

Mellor and Dr. David Munn, who leads the Cancer Immunotherapy Program in the GHSU Cancer Center and co-authored the study, led a research team that in 1998 identified IDO’s role in preventing a mother’s immune system from rejecting a fetus. They subsequently learned that tumors pirate the mechanism. The university has patented technologies to inhibit IDO, which are currently in clinical trials funded by the National Cancer Institute and corporate partners. “Tumors are really good at turning on IDO and after the cancer is found it becomes important to turn it off,” Mellor said.

The study also provides new insight into cancer treatment vaccines that have worked well in the laboratory but are less successful in patients, Mellor said.

It suggests that the quantity of bacterial mimics, which get the attention of the immune system, is pivotal. Mellor and his colleagues showed in 2005 that the bacterial mimic CpG-ODNs can actually activate IDO. The new study confirmed that a lower dose avoided stimulating IDO while higher doses turned it on.

It also may help explain a common cancer vaccine side effect: the immune system’s attack on healthy as well as cancerous tissue.

The Latest on: Energy Storage

March 16, 2018 - Younicos announced that it is launching a new “Energy-Storage-as-a-Service” rental offering, which allows customers to meet immediate storage requirements and tap into multiple opportunities in fast-evolving markets – without risk or long-term capit ...

March 16, 2018 - The large-scale energy storage technology pioneered by A123 Systems Inc., a high-flying Massachusetts battery company that eventually went bankrupt, will now be integrated into the ambitious Bay State Wind project taking shape off the coast of Martha's .. ...

March 16, 2018 - The mix reflects the needs and capabilities of individual areas within the Xcel service area, suggesting that no one form of power generation will supply all renewable energy the world needs in the future. In some areas, solar is the best choice. In ... ...

The Latest on: Internet of Things

March 17, 2018 - Internet of Things (IoT) has found its way into the fashion industry taking it to a whole new level. This revolutionary technology has something in store for everyone – fashion buffs, designers, retailers, and fashion market in general. Most of us, at . ...

March 16, 2018 - The National Institute for Standards in Technology is coordinating a pair of government reports dealing with cybersecurity standards for internet-of-things devices and combatting botnets, but any eventual recommendations will be non-binding, and NIST ... ...

March 16, 2018 - The internet of things (IoT) is a comparatively recent invention. Ten years ago, we only worried about protecting our computers, and it was only five years ago when we needed to protect our smartphones. Now we need to consider protecting our fridges ... ...

March 15, 2018 - This new variant was designed specially to attack Internet of Things devices. “The attack is a distributed denial of service attack, meaning the malware now can commandeer previously immune devices and use them to target large amounts of traffic at ... ...